Brief: Bio-Rad Q4 Sales USD 693.2 Million Vs. IBES Estimate USD 688.8 Million
12/02/2026 21:15
Feb 12 (Reuters) - Bio-Rad Q4 gross margin 49.8%. Q4 net income USD 720 million Q4 EPS USD 26.65 outlook FY adjusted revenue growth 0.5-1.5%
Recent news on Bio-Rad Laboratories
See all newsUS RESEARCH ROUNDUP-Cencora, Dave, Uber
Bio-Rad Laboratories, Inc. reports results for the quarter ended September 30 - Earnings Summary
Bio-Rad's Q3 revenue comes slightly above estimates on Clinical Diagnostics growth
Brief: Bio-Rad Q3 EBIT Margin -7.6%
Bio-Rad Laboratories, Inc. reports results for the quarter ended June 30 - Earnings Summary